Sam Brusco, Associate Editor03.30.23
Spinal implant designer and manufacturer CoreLink has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its new Siber Ti sacroiliac joint fusion system. Siber Ti includes a portfolio of porous, nano-surfaced, 3D-printed implants.
The new implants use CoreLink’s Mimetic Metal, which is engineered to emulate natural bone with a directional lattice architecture and trabecular pores. The implants also have features at the macro, micro, and nano levels.
In-vitro studies have shown, according to the company, that Mimetic Metal increased osteoblastic activity compared to machined solid titanium, PEEK, and HA-PEEK. In-vivo studies have also shown bony ingrowth and on-growth in cortical and cancellous bone.
Various diameter and length options give surgeons the ability to precisely fit patient anatomy. Dual-lead threads and varied pitch aim to provide true joint compression and strong purchase. Combined with self-harvesting threads, CoreLink believes this helps create the optimal opportunity for successful fusions.
“With the SI fusion market rapidly expanding, it’s important to choose implants best suited for my patients from companies with a history of success in the space,” Dr. Kris Radcliff told the press. “CoreLink Surgical has proven their success in this space with a strong SI portfolio for over 7 years. With their latest innovation—Siber Ti—I’ll have a completely comprehensive system that will allow me to choose what’s best for each patient’s unique surgical need.”
“At CoreLink our mission is to deliver life-changing options for patients, while offering innovative and efficient solutions to physicians and our entire healthcare system. The Siber Ti System accomplishes just that. Siber Ti will provide surgeons versatility for use in posterior, oblique, and lateral implantation approaches, while compression and non-compression implants allow for use in trauma and non-trauma related cases. It’s a very versatile and comprehensive system.” added Jay Bartling, CEO of CoreLink.
The new implants use CoreLink’s Mimetic Metal, which is engineered to emulate natural bone with a directional lattice architecture and trabecular pores. The implants also have features at the macro, micro, and nano levels.
In-vitro studies have shown, according to the company, that Mimetic Metal increased osteoblastic activity compared to machined solid titanium, PEEK, and HA-PEEK. In-vivo studies have also shown bony ingrowth and on-growth in cortical and cancellous bone.
Various diameter and length options give surgeons the ability to precisely fit patient anatomy. Dual-lead threads and varied pitch aim to provide true joint compression and strong purchase. Combined with self-harvesting threads, CoreLink believes this helps create the optimal opportunity for successful fusions.
“With the SI fusion market rapidly expanding, it’s important to choose implants best suited for my patients from companies with a history of success in the space,” Dr. Kris Radcliff told the press. “CoreLink Surgical has proven their success in this space with a strong SI portfolio for over 7 years. With their latest innovation—Siber Ti—I’ll have a completely comprehensive system that will allow me to choose what’s best for each patient’s unique surgical need.”
“At CoreLink our mission is to deliver life-changing options for patients, while offering innovative and efficient solutions to physicians and our entire healthcare system. The Siber Ti System accomplishes just that. Siber Ti will provide surgeons versatility for use in posterior, oblique, and lateral implantation approaches, while compression and non-compression implants allow for use in trauma and non-trauma related cases. It’s a very versatile and comprehensive system.” added Jay Bartling, CEO of CoreLink.
